Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspnea

Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspnea

ObjectivesIn dyspneic patients with atrial fibrillation (AF) or obesity, the diagnostic performance of NT-proBNP for acute heart failure is reduced. We evaluated the erythroblast derived protein erythroferrone (ERFE) as an ancillary biomarker for the diagnosis of acute decompensated heart failure (A...

Full description

Bibliographic Details
Main Authors: Sarah Appleby, Chris Frampton, Mark Holdaway, Janice Chew-Harris, Oi Wah Liew, Jenny Pek Ching Chong, Lynley Lewis, Richard Troughton, Shirley Beng Suat Ooi, Win Sen Kuan, Irwani Ibrahim, Siew Pang Chan, A. Mark Richards, Christopher J. Pemberton
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
erythroferrone
ERFE
acute decompensated heart failure
diagnosis
atrial fibrillation
obesity
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1195082/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1195082/full

Similar Items